Xencor (XNCR) Deferred Taxes (2016)

Xencor (XNCR) reported Deferred Taxes of $335000.0 for Q4 2016, down 75.74% quarter-over-quarter from $1.4 million in Q3 2016.

Xencor (XNCR) Deferred Taxes (2016) Analysis & Trends

Xencor (XNCR) has 1 years of Deferred Taxes data on file, last reported at $335000.0 in Q4 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -859,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -65.30 Mn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Xencor 953.38 Mn 878.64 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2016 335,000.00
Sep 30, 2016 1.38 Mn